Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver

Toxicological Sciences

Volumn 71, Issue 1, 2003, Pages 11-19

  Chang, Thomas K H ^a   Chen, Jie ^a   Pillay, Vincent ^a   Ho, Jeong Yau ^a   Bandiera, Stelvio M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cigarette smoke; CYP1A1; CYP1A2; CYP1B1; Cytochorme P450; Real time PCR

Indexed keywords

ANTIBODY; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER MICROSOME; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROTEIN EXPRESSION; REVIEW; SAMPLE; SMOKING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ARYL HYDROCARBON HYDROXYLASES; CALIBRATION; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOBLOTTING; MALE; MICROSOMES, LIVER; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKING;

EUKARYOTA;

EID: 0037260154     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/71.1.11     Document Type: Review

References (49)

1. Adams, D. J., Seilman, S., Amelizad, Z., Oesch, F., and Wolf, C. R. (1985). Identification of human cytochromes P-450 analogous to forms induced by phenobarbital and 3-methylcholanthrene in the rat. Biochem. J. 232, 869-876.
2. Baker, J. R., Satarug, S., Reilly, P. E. B., Edwards, R. J., Ariyoshi, N., Kamataki, T., Moore, M. R., and Williams, D. J. (2001). Relationships between non-occupational cadmium exposure and expression of nine cytochrome-P450 forms in human liver and kidney cortex samples. Biochem. Pharmacol. 62, 713-721.
3. Bartsch, H., Castegnaro, M., Rojas, M., Camus, A. M., Alexandrov, K., and Lang, M. (1992). Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high-risk subjects for tobacco-related lung cancer. Toxicol. Lett. 64-65, 477-483.
4. Bieche, I., Laurendeau, I., Tozlu, S., Olivi, M., Vidaud, D., Lidereau, R., and Vidaud, M. (1999). Quantitation of Myc gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res. 59, 2759-2765.
5. Butler, M. A., Iwasaki, M., Guengerich, F. P., and Kadlubar, F. F. (1989). Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A. 86, 7696-7700.
6. Chang, T. K. H., Lee, W. B. K., and Ko, H. H. (2000). Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can. J. Physiol. Pharmacol. 78, 874-881.
7. Christou, M., Savas, U., Spink, D. C., Gierthy, J. F., and Jefcoate, C. R. (1994). Co-expression of human CYP1A1 and a human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachloro-dibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis 15, 725-732.
8. Coumoul, X., Diry, M., Robillot, C., and Barouki, R. (2001). Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res. 61, 3942-3948.
9. Crofts, F. G., Strickland, P. T., Hayes, C. L., and Sutter, T. R. (1997). Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochrome P4501B1. Carcinogenesis 18, 1793-1798.
10. Drahushuk, A. T., McGarrigle, B. P., Larsen, K. E., Stegeman, J. J., and Olson, J. R. (1998). Detection of CYP1A1 protein in human liver and induction by TCDD in precision-cut liver slices incubated in dynamic organ culture. Carcinogenesis 19, 1361-1368.
11. Finnstrom, N., Thorn, M., Loof, L., and Rane, A. (2001). Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. Eur. J. Clin. Pharmacol. 57, 403-409.
12. Fleischmann, R., Remmer, H., and Starz, U. (1986). Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking. Eur. J. Clin. Pharmacol. 30, 475-480.
13. Guengerich, F. P., Parikh, A., Turesky, R. J., Josephy, P. D. (1999). Inter-individual differences in the metabolism of environmental toxicants: Cytochrome P450 1A2 as a prototype. Mutat. Res. 428, 115-124.
14. Hakkola, J., Pasanen, M., Purkunen, R., Saarikoski, S., Pelkonen, O., Maenpaa, J., Rane, A., and Raunio, H. (1994). Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem. Pharmacol. 48, 59-64.
15. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. (1996). 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA 93, 9776-9781.
16. Huang, Z., Fasco, M. J., Figge, H. L., Keyomarsi, K., and Kaminsky, L. S. (1996). Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos. 24, 899-905.
17. Jones, L. J., Yue, S. T., Cheung, C. Y., and Singer, V. L. (1998). RNA quantitation by fluorescence-based solution assay: RiboGreen reagent characterization. Anal. Biochem. 265, 368-374.
18. Lin, S., Bullock, P. L., Addison, R. F., and Bandiera, S. M. (1998). Detection of cytochrome P450 1A in several species, using antibody against a synthetic peptide derived from rainbow trout cytochrome P450 1A1. Environ. Toxicol. Chem. 17, 439-445.
19. Lu, A. Y. H., and Levin, W. (1972). Partial purification of cytochrome P-450 and P-448 from rat liver microsomes. Biochem. Biophys. Res. Commun. 46, 1334-1339.
20. Lucas, D., Berthou, F., Dreano, Y., Lozach, P., Volant, A., and Menez, J. F. (1993). Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcohol Clin. Exp. Res. 17, 900-905.
21. Luch, A., Schober, W., Soballa, V. J., Raab, G., Greim, H., Jacob, J., Doehmer, J., and Seidel, A. (1999). Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells. Chem. Res. Toxicol. 12, 353-364.
22. McFadyen, M. C. E., Breeman, S., Payne, S., Stirk, C., Miller, I. D., Melvin, W. T., and Murray, G. I. (1999). Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J. Histochem. Cytochem. 47, 1457-1464.
23. McFadyen, M. C. E., McLeod, H. L., Jackson, F. C., Melvin, W. T., Doehmer, J., and Murray, G. I. (2001). Cytochrome P450 CYP1B1 protein expression: A novel mechanism of anticancer drug resistance. Biochem. Pharmacol. 62, 207-212.
24. McKay, J. A., Melvin, W. T., Ah-See, A. K., Ewen, S. W. B., Greenlee, W. F., Marcus, C. B., Burke, M. D., and Murray, G. I. (1995). Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett. 374, 270-272.
25. McKinnon, R. A., de la Hall M. P., Quattrochi, L. C., Tukey, R. H., and McManus, M. E. (1991). Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization. Hepatology 14, 848-856.
26. McManus, M. E., Stupans, I., Ioannoni, B., Burgess, W., Robson, R. A., and Birkett, D. J. (1988). Identification and quantitation in human liver of cytochrome P-450 analogous to rabbit cytochrome P-450 forms 4 and 6. Xenobiotica 18, 207-216.
27. Mollerup, S., Ryberg, D., Hewer, A., Phillips, D. H., and Haugen, A. (1999). Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res. 59, 3317-3320.
28. Murray, B. P., Edwards, R. J., Murray, S., Singleton, A. M., Davies, D. S., and Boobis, A. R. (1993). Human hepatic CYP1A1 and CYP1A2 content, determined with specific antipeptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis 14, 585-592.
29. Murray, G. I., Melvin, W. T., Greenlee, W. F., and Burke, M. D. (2001). Regulation, function, and tissue-specific expression of cytochrome P450 1B1. Annu. Rev. Pharmacol. Toxicol. 41, 297-316.
30. Murray, G. I., Taylor, M. C., McFadyen, M. C. E., McKay, J. A., Greenlee, W. F., Burke, M. D., and Melvin, W. T. (1997). Tumor-specific expression of cytochrome P4501B1. Cancer Res. 57, 3026-3031.
31. Muskhelishvili, L., Thompson, P. A., Kusewitt, D. F., Wang, C., and Kadlubar, F. F. (2001). In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J. Histochem. Cytochem. 49, 229-236.
32. Omiecinski, C. J., Redlich, C. A., and Costa, P. (1990). Induction and developmental expression of cytochrome P450 IA1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res. 50, 4315-4321.
33. Pelkonen, O., Pasanen, M., Kuha, H., Gachalyi, B., Kairaluoma, M., Sotaniemi, E. A., Park, S. S., Friedman, F. K., and Gelboin, H. V. (1986). The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: Analyses with monoclonal antibodies. Br. J. Clin. Pharmacol. 22, 125-134.
34. Piipari, R., Savela, K., Nurminen, T., Hukkanen, J., Raunio, H., Hakkola, J., Mantyla, T., Beaune, P., Edwards, R. J., Boobis, A. R., and Anttila, S. (2000). Expression of CYP1A1, CYP1B1, and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and nonsmokers. Int. J. Cancer 86, 610-616.
35. Rodriguez-Antona, C., Donato, M. T., Pareja, E., Gomez-Lechon, M. J., and Castell, J. V. (2001). Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch. Biochem. Biophys. 393, 308-315.
36. Santostefano, M. J., Ross, D. G., Savas, U., Jefcoate, C. R., and Birnbaum, L. S. (1997). Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats. Biochem. Biophys. Res. Commun. 233, 20-24.
37. Schweikl, H., Taylor, J. A., Kitareewan, S., Linko, P., Nagorney, D., and Goldstein, J. A. (1993). Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 3, 239-249.
38. Sesardic, D., Boobis, A. R., Edwards, R. J., and Davies, D. S. (1988). A form of cytochrome P450 in man, orthologous to form d in the rat, catalyzes the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26, 363-372.
39. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. (1996). Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56, 2979-2984.
40. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. (1994). Inter-individual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414-423.
41. Singer, V. L., Jones, L. J., Yue, S. T., and Haugland, R. P. (1997). Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal. Biochem. 249, 228-238.
42. Spink, B. C., Fasco, M. J., Gierthy, J. F., and Spink, D. C. (1998). 12-O-Tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells. J. Cell. Biochem. 70, 289-296.
43. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. (1994). Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269, 13092-13099.
44. Tang, Y. M., Chen, G. F., Thompson, P. A., Lin, D. X., Lang, N. P., and Kadlubar, F. F. (1999). Development of an antipeptide antibody that binds to the C-teminal region of human CYP1B1. Drug Metab. Dispos. 27, 274-280.
45. Whitlock, J. P., Jr. (1999). Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39, 103-125.
46. Wong, J. M. Y., Okey, A. B., and Harper, P. A. (2001). Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem. Biophys. Res. Commun. 288, 990-996.
47. Wrighton, S. A., Campanile, C., Thomas, P. E., Maines, S. L., Watkins, P. B., Parker, G., Mendez-Picon, G., Haniu, M., Shively, J. E., Levin, W., and Guzelian, P. S. (1986). Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Mol. Pharmacol. 29, 405-410.
48. Wrighton, S. A., VandenBranden, M., and Ring, B. J. (1996). The human drug metabolizing cytochromes P450. J. Pharmacokinet. Biopharm. 24, 461-473.
49. Yager, J. D., and Liehr, J. G. (1996). Molecular mechanisms of estrogen carcinogenesis. Anna. Rev. Pharmacol. Toxicol. 36, 203-232.